Bioanalytical services: Concept Life Sciences

Bioanalytical Services and the importance of continuity:

  • Removing lab variability from Discovery PK through to Phase IIb clinical studies (D2C) 
  • Tailoring rapid, fit-for-purpose methodology to support non-regulatory studies (PK, MTD and DRF) 
  • Development of fit-for-purpose methods into fully FDA and EMEA compliant assays to support regulatory studies (preclinical GLP support and clinical bioanalysis)


Not registered yet? Create an account